The zebrafish is currently one of the most important vertebrate models to study cellular and developmental processes in vivo. This is largely due to the zebrafish's optical transparency and amenability to genetics, which makes it a powerful model for applying optical techniques involving genetically encoded photoresponsive protein technologies1. Specific to the study of heart development, zebrafish receive sufficient oxygen via diffusion such that even mutants without heartbeat can survive through the first week of development, permitting analyses on the effects of developmental genes and perturbed blood flow on heart morphogenesis not possible in most vertebrates2.
The zebrafish heart tube is formed by 24 hours post fertilization (hpf). Shortly after its formation, the heart tube starts actively beating. By 36 hpf, a clear constriction separates the atrium from the ventricle. This region of constriction is called the atrioventricular canal (AVC), and cells in this region change from a squamous morphology to a cuboidal morphology3. Zebrafish atrioventricular valve morphogenesis starts around 48 h post fertilization. By 5 days post fertilization, two valve leaflets extend into the AVC and prevent the back flow of blood from the ventricle to the atrium during the cardiac cycle4. Tracking cells during AVC and valve formation is challenging as the rapid beating of the heart makes it difficult to follow cells via traditional time-lapse microscopy5,6. This protocol, adapted from Steed et al., 20167, describes a method that uses the Tg(fli1a:gal4FFubs, UAS:kaede)8 zebrafish transgenic line, in which the photoconvertible protein Kaede is expressed in endothelial cells, including the endocardium. The drug 2,3-butanedione-2-monoxime (BDM) is used to temporarily stop the heart beating, allowing accurate photoconversion of EdCs between 36 and 55 hpf, and high-resolution imaging of photoconverted EdCs at specific developmental time points. It has previously been shown that EdCs photoconverted using this method can remain distinguishable from their unconverted neighbors for five days or more after the time of photoconversion7. This protocol also details a method used for image analysis of photoconverted EdCs in embryos younger than 48 hpf, which has successfully been used to follow tissue movements during AVC development (Boselli et al., in press)9. We hope that readers would find this protocol useful for studying AVC and valve development in normal embryos, and in mutants, morphants, or drug-treated embryos. For a more general protocol relating to cell tracking using photoconvertible proteins during zebrafish development, please view the article by Lombardo et al., 201210.